Clinical Trial Update: Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cyproheptadine and megestrol to prevent weight loss in children with cancer-related cachexia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Cancer Cachexia
• Central Nervous System Tumors
• Leukemia
• Lymphoma
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes
• Solid Tumors

Drugs mentioned

• Cyproheptadine (cyproheptadine)
• Megestrol acetate (megestrol acetate)

Snippet

Sponsor: University of South Florida | Conditions: Brain Tumor, Central Nervous System Tumors | Phase 2 | Status: COMPLETED